How Long Do Pacemakers Last and When to Replace Them

Gain insight into pacemaker longevity, the key elements impacting its lifespan, and the proactive care ensuring optimal cardiac function.

Most modern pacemakers last somewhere between 6 and 15 years before the battery needs replacing, with the typical range for standard dual-chamber devices falling around 8 to 12 years. That spread is wide because battery life depends heavily on what kind of pacemaker you have, how often it actually paces your heart, and how its settings are programmed. Replacement is usually a straightforward outpatient procedure, but the timing depends on specific warning signs your doctor monitors at routine checkups or through remote transmissions from the device itself.

What Determines How Long a Pacemaker Lasts

Pacemaker batteries are not like phone batteries that you drain and recharge. They are sealed lithium-iodine cells (or in newer devices, lithium oxyhalide cells) designed to deliver a steady trickle of energy over many years and then be swapped out entirely when they run low. The single biggest factor determining how quickly that battery drains is how much pacing the device actually does. A pacemaker implanted as a safety net for someone who only needs it occasionally will outlast one that paces every single beat. In studies of defibrillator-pacemaker combos, the percentage of beats that were paced was one of the strongest predictors of battery drain, along with the voltage and pulse width programmed into each pacing output.

Programming matters more than people realize. Higher pacing voltage means the electrical pulse delivered to your heart muscle is stronger, which uses more energy. Your doctor sets the voltage just above the minimum needed to reliably capture your heartbeat. Modern devices have automatic capture management features that continuously test the threshold and lower the voltage to the minimum effective level. In a randomized trial, turning on automatic ventricular capture lowered the average pacing voltage from about 3.1 volts to 1.6 volts and extended projected device longevity from roughly 9 years to over 10 years. When multiple automatic optimization features are combined, the added battery life can reach almost two extra years.

Other factors play smaller but real roles. Your resting heart rate matters because a faster rate means more pacing pulses per minute. Using a rate-response feature, which speeds up the pacemaker during physical activity, also adds to consumption. And additional monitoring features like remote transmission draw power too, though the trade-off in clinical benefit is usually worth it.

How Long Different Types of Pacemakers Last

Not all pacemakers are created equal when it comes to battery life, and the type of device you have sets the baseline. A large real-world study tracking nearly 1,500 dual-chamber transvenous pacemakers found that median battery longevity ranged from about 8.5 years to just over 10 years, depending on the manufacturer. Single-chamber pacemakers performed similarly, ranging from roughly 8.75 to 10 years. CRT pacemakers, which coordinate the heart’s chambers in patients with heart failure, drained faster. Full CRT-P systems lasted about 6.5 to 8 years, and simpler CRT configurations varied even more widely.

Manufacturer-stated design lives tend to be more optimistic because they assume particular pacing settings that may not match real-world use. One cost-analysis study found designed lives averaging around 13 years for standard dual-chamber and single-chamber devices, while CRT-P devices came in closer to 9 years and CRT-D devices around 8.5 years. A modeling study found that newer-generation conventional pacemakers show genuine improvement over older ones, with estimated longevity climbing to about 15 years for single-chamber and 14 years for dual-chamber devices in current models. That is a meaningful gain over older generations, which came in around 11 years. The progress comes from more efficient circuitry and better batteries rather than any single breakthrough.

The gap between designed life and observed life is worth keeping in mind. If your cardiologist tells you to expect 10 to 12 years from a standard pacemaker, that is a reasonable middle-ground estimate for most patients. But if you pace heavily, as some heart-block patients do at nearly 100% of the time, expect the lower end of the range. And if your device mostly monitors rather than paces, you may be pleasantly surprised by how long it holds up.

How Your Doctor Knows When the Battery Is Running Low

Pacemakers do not just die without warning. They are designed with built-in indicators that flag the approaching end of battery life well before the device stops working. The key milestone is called the elective replacement indicator, or ERI. When the battery voltage drops to a preset level, the device shifts into a simplified pacing mode and reports the change at the next check. Reaching ERI does not mean the pacemaker has failed. It means you have a window of time to schedule a replacement at your convenience rather than in an emergency.

How long that window lasts varies. Older research on implantable defibrillators found that the average time from ERI to the point where the device truly needed to be swapped was about 8 months, with a wide range. In patients whose devices had fired to treat dangerous heart rhythms, that buffer was shorter, around 6 months on average. For those without such discharges, it stretched to nearly a year. Modern pacemakers generally provide a similar cushion of several months. Your electrophysiologist will schedule the replacement promptly after ERI, typically within a few weeks, since there is little reason to push the boundary.

Remote monitoring has changed how this process works in practice. Instead of catching battery depletion only at a scheduled office visit every six months or year, most modern pacemakers transmit data to your care team regularly. This means the device’s battery status, lead performance, and any abnormal events are reviewed between visits. Research has linked remote monitoring to longer effective battery lives because clinicians can adjust settings earlier when they spot unnecessary energy use, and because problems like lead issues that increase pacing demands are caught sooner. If you have a pacemaker with remote monitoring capability and it is not set up, ask your clinic about enabling it.

What Happens During Replacement Surgery

Pacemaker replacement is considerably simpler than the original implant. In most cases, the surgeon reopens the small incision over the device pocket in your upper chest, disconnects the old generator from the leads, and connects a new generator to the same leads. The leads themselves, which are thin wires threaded through veins into the heart, are usually left in place as long as they are functioning well. The procedure is typically done under local anesthesia with sedation and takes under an hour.

The complication rate is low but not zero. A study of over 700 pulse generator replacements found that complications requiring some form of intervention occurred in about 1.2% of patients, including pocket infections and hematomas (blood collections under the skin). A separate study of replacements done specifically because of manufacturer advisories reported a higher overall complication rate of about 4% for major issues, which included lead damage during the procedure and pocket problems requiring additional surgery. The difference likely reflects that advisory-driven replacements happen on a timeline set by the recall rather than by clinical need, sometimes on devices that have been implanted for a shorter time and are more firmly adhered in the pocket.

Infection is the most concerning risk with any pacemaker procedure, and the risk is somewhat higher with replacements than with first implants because the pocket has been opened before. An antibacterial envelope, a mesh pouch that wraps around the device and slowly releases antibiotics, has been shown to cut infection rates. In the large WRAP-IT trial, using the envelope reduced major device-related infections by about 40% over the follow-up period. Real-world data has shown even larger reductions in some cohorts, with infection rates dropping from around 1.8% to 0.3% when the envelope was used in pacemaker patients. If you are undergoing a replacement and have risk factors for infection, such as diabetes, kidney disease, or a history of prior device infection, it is reasonable to ask your doctor whether an antibacterial envelope will be used.

Leads Are Often the Weak Link

While the generator replacement itself is straightforward, the leads present a trickier long-term challenge. Every time a generator is swapped, the leads are handled, disconnected, tested, and reconnected. That manipulation adds mechanical stress over the life of the system. Research has shown that generator replacement and other device procedures increase the probability that a lead will eventually need to be extracted due to mechanical damage or infection. In a study that matched leads by age, the risk of extraction for mechanical damage rose significantly after a reimplantation, and the infection-related extraction risk increased further after upgrade or revision procedures.

Lead extraction is a far more involved procedure than a simple generator swap. It carries risks of vascular damage and is done in specialized centers. For most patients, leads remain functional for decades, and the risk from any single generator change is small. But for younger patients who may go through four or five generators over a lifetime, the cumulative risk of lead complications is a real clinical concern. It is one of the driving motivations behind the development of leadless pacemakers.

Leadless Pacemakers and the Replacement Puzzle

Leadless pacemakers, small capsule-shaped devices implanted directly inside the heart through a catheter in the leg vein, eliminate the leads and the chest pocket entirely. That removes the risks of lead fracture, pocket infection, and the cosmetic concerns of a visible lump under the skin. But they introduce a new question: what happens when the battery runs out?

Early data on the newer dual-chamber leadless system shows estimated total battery longevity of roughly 5 years for the atrial capsule and about 10 years for the ventricular capsule. The atrial unit drains faster because the two capsules must communicate wirelessly with each other, which costs energy. Programming the communication intensity to lower levels can extend the atrial capsule’s life meaningfully. Modeling of single-chamber leadless devices puts their longevity at about 10 to 11 years, comparable to conventional pacemakers for the ventricular component but with the atrial capsule being a weaker point in dual systems.

When a leadless pacemaker’s battery is depleted, two strategies are on the table. One is to retrieve the old device and implant a new one in its place. A single-center study demonstrated that retrieval of leadless pacemakers implanted for an average of about four years was feasible and safe, with an 85% success rate. The other option is to simply leave the depleted device in place and implant a second leadless pacemaker alongside it. Both approaches have trade-offs. Retrieval avoids accumulating inactive hardware in the heart but carries procedural risk, especially if the device has become encased in tissue over many years. Leaving it in place is simpler but raises questions about how many inactive capsules the right ventricle can accommodate over a patient’s lifetime. For older patients who may only need one device in their lifetime, this is less of a concern. For younger patients, it remains an active area of clinical discussion.

Device Recalls and Unexpected Failures

Most pacemaker replacements happen on schedule, driven by predictable battery depletion. But occasionally a device develops a defect that forces replacement ahead of time. Manufacturer advisories and recalls, while uncommon, do occur. In a well-documented case involving a heart failure pacemaker, several patients experienced syncope (fainting) when their devices intermittently or permanently stopped pacing due to manufacturing defects, including issues with internal circuitry. These failures happened around six to seven years after implant, before normal end-of-battery-life indicators would have triggered replacement.

Recalls create a difficult situation because the replacement surgery carries its own risks, as noted earlier. The decision to replace a recalled device that is still functioning involves weighing a small but real surgical complication rate against the probability of the defect actually affecting your particular unit. This is a conversation between you and your electrophysiologist, not something to navigate alone based on a news headline. Remote monitoring is especially valuable in these situations because it allows continuous surveillance for the early electrical signs of a malfunction.

Energy Harvesting and the Prospect of Battery-Free Pacemakers

The most radical solution to the battery problem would be to eliminate batteries altogether. Several research groups are developing devices that harvest energy from the heart’s own motion to power pacing. One approach uses piezoelectric materials, which generate electricity when bent or compressed by the beating heart. Another uses triboelectric nanogenerators, which create charge from contact and separation of materials. A team demonstrated a self-powered leadless pacemaker in a pig model that reliably paced the heart using only harvested energy from heartbeats, generating enough power density to sustain pacing at physiological heart rates. A separate group achieved similar results with a capsule-shaped device implanted in swine through a standard catheter, producing about 6 volts from cardiac motion over a three-week follow-up period.

These are animal studies and proof-of-concept demonstrations, not devices you can get implanted. The gap between a prototype that works in a pig for three weeks and a clinical device that works in a human for 15 years is enormous, involving long-term biocompatibility, miniaturization, regulatory approval, and reliability testing. But the physics works, and the engineering is progressing. If these devices reach the clinic, they could make the entire question of battery replacement obsolete for future patients.

When Not Replacing a Pacemaker Is the Right Decision

Not every patient whose pacemaker reaches end of life should automatically receive a new one. For people with terminal illnesses or those nearing the end of life, the risks and discomfort of replacement surgery may outweigh the benefit. Professional guidelines recognize that choosing not to replace a depleted device is a legitimate option and is ethically distinct from active withdrawal of treatment. The 2010 Heart Rhythm Society expert consensus statement explicitly states that patients or their surrogates may choose not to replace a device when the generator becomes depleted, noting that the invasive replacement procedure carries risks including infection that could hasten death.

This conversation often does not happen early enough. Research on the psychosocial experience of pacemaker patients finds that anxiety about the device is common and frequently stems from misconceptions about what the pacemaker does and what would happen without it. Many patients believe their heart would stop immediately if the pacemaker were turned off, which is true for the minority who are completely pacemaker-dependent but not for the majority. Understanding your level of dependence on the device is something worth discussing with your cardiologist well before end-of-life decisions arise, because it shapes what options you actually have and removes some of the fear that surrounds the topic.